Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Lifecore Biomedical, Inc. (LFCR) had Cost of Goods Sold of $22.09M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$34.17M |
|
$-7.13M |
|
|
Cost of Goods Sold |
$22.09M |
$12.07M |
|
$31.60M |
|
$2.57M |
|
$-8.70M |
|
$-6.13M |
|
$-6.13M |
|
$-6.16M |
|
$-6.16M |
|
$-6.16M |
|
$-6.16M |
|
$2.57M |
|
$5.08M |
|
37.58M |
|
37.58M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$83.69M |
|
$123.71M |
|
$145.81M |
|
$229.50M |
|
$21.64M |
|
$185.02M |
|
$191.77M |
|
$213.41M |
|
$-34.09M |
|
$2.21M |
|
$16.09M |
|
37.70M |
|
| Cash Flow Statement Financials | |
$2.51M |
|
$-1.63M |
|
$-1.11M |
|
$17.47M |
|
$17.24M |
|
$-0.23M |
|
$3.78M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.87 |
|
-- |
|
-- |
|
0.92 |
|
11.50 |
|
35.34% |
|
7.51% |
|
7.51% |
|
-- |
|
-17.95% |
|
-20.86% |
|
$0.88M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.87 |
|
1.12 |
|
80.22 |
|
18.06% |
|
-278.30% |
|
-2.68% |
|
-3.06% |
|
$0.43 |
|
$0.02 |
|
$0.07 |
|